2022-03-012023-06-302023-06-30false10639874BRUTOU HEALTHCARE LIMITED2024-02-2986220iso4217:GBPxbrli:pure106398742022-03-01106398742023-06-30106398742022-03-012023-06-30106398742021-03-01106398742022-02-28106398742021-03-012022-02-2810639874bus:SmallEntities2022-03-012023-06-3010639874bus:AuditExempt-NoAccountantsReport2022-03-012023-06-3010639874bus:AbridgedAccounts2022-03-012023-06-3010639874bus:PrivateLimitedCompanyLtd2022-03-012023-06-3010639874core:WithinOneYear2023-06-3010639874core:AfterOneYear2023-06-3010639874core:WithinOneYear2022-02-2810639874core:AfterOneYear2022-02-2810639874core:ShareCapital2023-06-3010639874core:SharePremium2023-06-3010639874core:RevaluationReserve2023-06-3010639874core:OtherReservesSubtotal2023-06-3010639874core:RetainedEarningsAccumulatedLosses2023-06-3010639874core:ShareCapital2022-02-2810639874core:SharePremium2022-02-2810639874core:RevaluationReserve2022-02-2810639874core:OtherReservesSubtotal2022-02-2810639874core:RetainedEarningsAccumulatedLosses2022-02-2810639874core:LandBuildings2023-06-3010639874core:PlantMachinery2023-06-3010639874core:Vehicles2023-06-3010639874core:FurnitureFittings2023-06-3010639874core:OfficeEquipment2023-06-3010639874core:NetGoodwill2023-06-3010639874core:IntangibleAssetsOtherThanGoodwill2023-06-3010639874core:ListedExchangeTraded2023-06-3010639874core:UnlistedNon-exchangeTraded2023-06-3010639874core:LandBuildings2022-02-2810639874core:PlantMachinery2022-02-2810639874core:Vehicles2022-02-2810639874core:FurnitureFittings2022-02-2810639874core:OfficeEquipment2022-02-2810639874core:NetGoodwill2022-02-2810639874core:IntangibleAssetsOtherThanGoodwill2022-02-2810639874core:ListedExchangeTraded2022-02-2810639874core:UnlistedNon-exchangeTraded2022-02-2810639874core:LandBuildings2022-03-012023-06-3010639874core:PlantMachinery2022-03-012023-06-3010639874core:Vehicles2022-03-012023-06-3010639874core:FurnitureFittings2022-03-012023-06-3010639874core:OfficeEquipment2022-03-012023-06-3010639874core:NetGoodwill2022-03-012023-06-3010639874core:IntangibleAssetsOtherThanGoodwill2022-03-012023-06-3010639874core:ListedExchangeTraded2022-03-012023-06-3010639874core:UnlistedNon-exchangeTraded2022-03-012023-06-3010639874core:MoreThanFiveYears2022-03-012023-06-3010639874core:Non-currentFinancialInstruments2023-06-3010639874core:Non-currentFinancialInstruments2022-02-2810639874dpl:CostSales2022-03-012023-06-3010639874dpl:DistributionCosts2022-03-012023-06-3010639874core:LandBuildings2022-03-012023-06-3010639874core:PlantMachinery2022-03-012023-06-3010639874core:Vehicles2022-03-012023-06-3010639874core:FurnitureFittings2022-03-012023-06-3010639874core:OfficeEquipment2022-03-012023-06-3010639874dpl:AdministrativeExpenses2022-03-012023-06-3010639874core:NetGoodwill2022-03-012023-06-3010639874core:IntangibleAssetsOtherThanGoodwill2022-03-012023-06-3010639874dpl:GroupUndertakings2022-03-012023-06-3010639874dpl:ParticipatingInterests2022-03-012023-06-3010639874dpl:GroupUndertakingscore:ListedExchangeTraded2022-03-012023-06-3010639874core:ListedExchangeTraded2022-03-012023-06-3010639874dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-03-012023-06-3010639874core:UnlistedNon-exchangeTraded2022-03-012023-06-3010639874dpl:CostSales2021-03-012022-02-2810639874dpl:DistributionCosts2021-03-012022-02-2810639874core:LandBuildings2021-03-012022-02-2810639874core:PlantMachinery2021-03-012022-02-2810639874core:Vehicles2021-03-012022-02-2810639874core:FurnitureFittings2021-03-012022-02-2810639874core:OfficeEquipment2021-03-012022-02-2810639874dpl:AdministrativeExpenses2021-03-012022-02-2810639874core:NetGoodwill2021-03-012022-02-2810639874core:IntangibleAssetsOtherThanGoodwill2021-03-012022-02-2810639874dpl:GroupUndertakings2021-03-012022-02-2810639874dpl:ParticipatingInterests2021-03-012022-02-2810639874dpl:GroupUndertakingscore:ListedExchangeTraded2021-03-012022-02-2810639874core:ListedExchangeTraded2021-03-012022-02-2810639874dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-03-012022-02-2810639874core:UnlistedNon-exchangeTraded2021-03-012022-02-2810639874core:NetGoodwill2023-06-3010639874core:IntangibleAssetsOtherThanGoodwill2023-06-3010639874core:LandBuildings2023-06-3010639874core:PlantMachinery2023-06-3010639874core:Vehicles2023-06-3010639874core:FurnitureFittings2023-06-3010639874core:OfficeEquipment2023-06-3010639874core:AfterOneYear2023-06-3010639874core:WithinOneYear2023-06-3010639874core:ListedExchangeTraded2023-06-3010639874core:UnlistedNon-exchangeTraded2023-06-3010639874core:ShareCapital2023-06-3010639874core:SharePremium2023-06-3010639874core:RevaluationReserve2023-06-3010639874core:OtherReservesSubtotal2023-06-3010639874core:RetainedEarningsAccumulatedLosses2023-06-3010639874core:NetGoodwill2022-02-2810639874core:IntangibleAssetsOtherThanGoodwill2022-02-2810639874core:LandBuildings2022-02-2810639874core:PlantMachinery2022-02-2810639874core:Vehicles2022-02-2810639874core:FurnitureFittings2022-02-2810639874core:OfficeEquipment2022-02-2810639874core:AfterOneYear2022-02-2810639874core:WithinOneYear2022-02-2810639874core:ListedExchangeTraded2022-02-2810639874core:UnlistedNon-exchangeTraded2022-02-2810639874core:ShareCapital2022-02-2810639874core:SharePremium2022-02-2810639874core:RevaluationReserve2022-02-2810639874core:OtherReservesSubtotal2022-02-2810639874core:RetainedEarningsAccumulatedLosses2022-02-2810639874core:NetGoodwill2021-03-0110639874core:IntangibleAssetsOtherThanGoodwill2021-03-0110639874core:LandBuildings2021-03-0110639874core:PlantMachinery2021-03-0110639874core:Vehicles2021-03-0110639874core:FurnitureFittings2021-03-0110639874core:OfficeEquipment2021-03-0110639874core:AfterOneYear2021-03-0110639874core:WithinOneYear2021-03-0110639874core:ListedExchangeTraded2021-03-0110639874core:UnlistedNon-exchangeTraded2021-03-0110639874core:ShareCapital2021-03-0110639874core:SharePremium2021-03-0110639874core:RevaluationReserve2021-03-0110639874core:OtherReservesSubtotal2021-03-0110639874core:RetainedEarningsAccumulatedLosses2021-03-0110639874core:AfterOneYear2022-03-012023-06-3010639874core:WithinOneYear2022-03-012023-06-3010639874core:Non-currentFinancialInstrumentscore:CostValuation2022-03-012023-06-3010639874core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-03-012023-06-3010639874core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-03-012023-06-3010639874core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-03-012023-06-3010639874core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-03-012023-06-3010639874core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-03-012023-06-3010639874core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-03-012023-06-3010639874core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-03-012023-06-3010639874core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-03-012023-06-3010639874core:Non-currentFinancialInstrumentscore:CostValuation2023-06-3010639874core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-3010639874core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-3010639874core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-3010639874core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-3010639874core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-3010639874core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-3010639874core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-3010639874core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-3010639874core:Non-currentFinancialInstrumentscore:CostValuation2022-02-2810639874core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-02-2810639874core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-02-2810639874core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-02-2810639874core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-02-2810639874core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-02-2810639874core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-02-2810639874core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-02-2810639874core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-02-2810639874bus:Director12022-03-012023-06-30

BRUTOU HEALTHCARE LIMITED

Registered Number
10639874
(England and Wales)

Unaudited Financial Statements for the Period ended
30 June 2023

BRUTOU HEALTHCARE LIMITED
Company Information
for the period from 1 March 2022 to 30 June 2023

Director

TOUPAN, Bruno

Registered Address

145-149 Cardigan Road
Leeds
LS6 1LJ

Registered Number

10639874 (England and Wales)
BRUTOU HEALTHCARE LIMITED
Balance Sheet as at
30 June 2023

Notes

30 Jun 2023

28 Feb 2022

£

£

£

£

Current assets
Debtors49,30048,848
49,30048,848
Creditors amounts falling due within one year(92,871)(65,259)
Net current assets (liabilities)(43,571)(16,411)
Total assets less current liabilities(43,571)(16,411)
Net assets(43,571)(16,411)
Capital and reserves
Profit and loss account(43,571)(16,411)
Shareholders' funds(43,571)(16,411)
The financial statements were approved and authorised for issue by the Director on 29 February 2024, and are signed on its behalf by:
TOUPAN, Bruno
Director
Registered Company No. 10639874
BRUTOU HEALTHCARE LIMITED
Notes to the Financial Statements
for the period ended 30 June 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2.Average number of employees

20232022
Average number of employees during the year00